Search Results - "Abrio, M. V."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population

    Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population by Castellano, D., del Muro, X. Garcia, Pérez-Gracia, J. L., González-Larriba, J. L., Abrio, M. V., Ruiz, M. A., Pardo, A., Guzmán, C., Cerezo, S. Díaz, Grande, E.

    Published in Annals of oncology (01-11-2009)
    “…Background: The purpose of this study is to evaluate the impact on the health-related quality of life (HRQoL) of sunitinib versus interferon-alpha (IFN-α)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-I- as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population

    Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-I- as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population by Castellano, D, del Muro, XGarcia, Perez-Gracia, J L, GonzA!lez-Larriba, JL, Abrio, M V, Ruiz, MA, Pardo, A, GuzmA!n, C, Cerezo, SDiaz, Grande, E

    Published in Annals of oncology (01-11-2009)
    “…Background: The purpose of this study is to evaluate the impact on the health-related quality of life (HRQoL) of sunitinib versus interferon-alpha (IFN-I-)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population

    Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population by Castellano, D, del Muro, X Garcia, Pérez-Gracia, J L, González-Larriba, J L, Abrio, M V, Ruiz, M A, Pardo, A, Guzmán, C, Cerezo, S Díaz, Grande, E

    Published in Annals of oncology (01-11-2009)
    “…The purpose of this study is to evaluate the impact on the health-related quality of life (HRQoL) of sunitinib versus interferon-alpha (IFN-alpha) treatment in…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Histiocytosis of the Langerhans cells with cerebellar and pyramidal involvement. Response to treatment with chemotherapy

    Histiocytosis of the Langerhans cells with cerebellar and pyramidal involvement. Response to treatment with chemotherapy by Martínez-Fernández, E, Gil-Néciga, E, López-Domínguez, J M, Casado-Chocán, J L, Garzón, F, Franco, E, Abrio, M V

    Published in Revista de neurologiá (16-12-1999)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Pigmented xerodermoid and multiple keratoacanthomatosis. Apropos of a case

    Pigmented xerodermoid and multiple keratoacanthomatosis. Apropos of a case by Murillo Capitán, E, Valero Jiménez, P, Torija Busto, E, Sánchez Romero, J A, Abrio Odriozola, M V, Pastor Gaitán, P

    Published in Actas dermo-sifiliográficas (01-07-1981)
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: